Bristol-Myers Squibb   2Q Revenues: $4.0 billion (-9%)   2Q Earnings: $536 million (-17%)   YTD Revenues: $7.9 billion (-19%)   YTD Earnings: $1.1 billion (-34%)   Comments: U.S. sales decreased 22% to $2.0 billion in the quarter and international sales increased 10% to $2.0 billion. Due to continued generic erosion, Abilify sales declined 21% to $563 million in the quarter, Plavix sales dropped 94% to $44 million, and Avapro/Avalide sales were down 52% to $56 million. Baraclude sales were $371 ...